appliedtherapeutics.com - Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi APLT
The absolute cash result of operations demonstrates the efficiency of robotic molecule modeling for the therapy of rare pathologies for Applied Therapeutics (APLT). However, 0.00 captures the current state of the parameter against a backdrop of dependence on FDA verdicts and critical liquidity levels. Growth prospects are based on the market launch of the govorestat and the absence of competitors in narrow niches of metabolic medicine.
Ringkesan rincian data analitis Applied Therapeutics (APLT)
- nilai saham lan prakiraan konsensus rega:
- rincian nilai pasar emiten:
- indikator kapitalisasi buku:
- rincian struktur utang lan likuiditas bisnis:
Rasio Kabeh Utang marang Dana Pribadi Applied Therapeutics|APLT - Utang jangka dawa marang ekuitas|Kewajiban jangka cendhak marang ekuitas appliedtherapeutics.com|APLT - Gunggung utang perusahaan|Rasio utang marang aset resik Applied Therapeutics|APLT - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Applied Therapeutics|Rasio jangkoan perantara appliedtherapeutics.com
- rincian bathi lan kelipatan pasar:
APLT - Bathi resik perusahaan|Bathi mangsa ngarep Applied Therapeutics|APLT - Pangali P/E|Pangali Forward P/E Applied Therapeutics Inc.|APLT - Pangali PEG|Pangali EV/EBITDA Applied Therapeutics|APLT - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben siji saham sajrone 12 wulan pungkasan Applied Therapeutics|APLT - Bathi saben saham sajrone rolas wulan pungkasan|Dinamika bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan appliedtherapeutics.com|APLT - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Applied Therapeutics
Ringkesan analitik perusahaan:Applied Therapeutics Inc.
Applied Therapeutics' specialization in high-cost therapies for rare genetic pathologies establishes a foundation for high margins per product unit. The company's EBITDA dynamics reflect daily cash flow from core operations, eliminating the time gap between quarterly reports; meanwhile, the upward trend confirms operational resilience, while sharp peaks signal a risk of asset overvaluation.
Karo sapa Applied Therapeutics saingan
Pendapatan operasional sadurunge ngurangi amortisasi Vertex Corp (VRTX)|ALNY: Bathi operasional sadurunge ngurangi amortisasi|Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi INSM|UTHR: Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi BioMarin Pharmaceutical Inc. (BMRN)|BBIO (BridgeBio Pharma Inc) - Bathi operasional EBITDA|Bathi operasional sadurunge amortisasi BGM (BGM Group Corp)|Bathi operasional sadurunge ngurangi amortisasi COGT (Cogent Biosciences)|XERS (xerispharma.com) - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Keros Therapeutics, Inc. KROS|ARCT (Arcturus Therapeutics Inc) - Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|Eton Pharma - Bathi operasional EBITDA|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi KMDA (Kamada Pharma)|FULC: Bathi operasional EBITDA|Abeona Therapeutics Inc. (ABEO) - Bathi operasional EBITDA|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Mereo BioPharma Group|PLX: Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Pliant Therapeutics (PLRX)|Bathi operasional sadurunge ngurangi amortisasi Aileron Therapeutics RNTX|Bathi operasional EBITDA GELS (Gelteq)|Bathi operasional EBITDA Aytu BioPharma Inc AYTU|Chemomab - Bathi operasional EBITDA|SRXH - Bathi operasional EBITDA|polyrizon-biotech.com (PLRZ) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi AEZS (Aeterna Zentaris Inc.)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Cyclo Therapeutics|Inozyme - Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Reneo Pharmaceuticals, Inc. (RPHM)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi CSCI (COSCIENS Biopharma Inc)
